Aesica Pharmaceuticals’ recent acquisitions in Europe have not only doubled the size of its business, but also significantly enhanced its extensive range of packaging services.
Two of the company’s new European sites; Monheim and Pianezza have consolidated Aesica’s packaging capabilities and compliment the existing facilities at its established Queenborough, UK site. Aesica’s expertise now includes fully integrated lines with the latest in line printing technology; dedicated to supplying the Japanese market and for the packing of pouched patches and syringes.
By 2013, two thirds of Aesica’s business will comprise the manufacture of formulated products including packaging services. As such the company plans to continue to develop its portfolio of services and enhance assets and capabilities across its six manufacturing sites.
Aesica has four sites dedicated to the manufacture of formulated products. Currently, the company’s site in Monheim, Germany, has extensive packaging experience and Aesica now offers a broad range of dosage forms including syringes and
pouches. In addition, the site in Pianezza, Italy, has packaging facilities for oral solid, oral liquid and injectable forms and Aesica’s site in Queenborough, Kent offers bottle and blister packaging as well as device assembly.
Simon Clough, Managing Director, Formulated Products Business Unit, Aesica, says: “Prior to the acquisition of our three new sites in Europe, Aesica already had huge capability and expertise in terms of packaging and following our recent acquisitions we now offer an even broader range of services. In addition to traditional packaging provision we also offer artwork, design, labeling and coding, supply chain management and regulatory affairs services, as we understand the value of providing a full contract manufacturing service to our clients.”